Personalized Oncology

Tempus Uses AI and Big Data for Precision Medicine

When you’ve been writing about technology for as long as we have at Nanalyze you start to see patterns emerge. One of the most interesting – and potentially biggest game-changers in the life sciences arena – is the emergence of precision medicine. The approach takes into account individual variability in genes, among other factors, to […]

Biodesix – A Lung Cancer Diagnostics Stock

One can’t help but wonder why the Americans are so worried about peanut allergies when 34 million of them use a product every day that slowly kills them. In the United States, cigarette smoking is linked to about 80% to 90% of lung cancer deaths. While we may not be able to pry someone’s cigarettes from their […]

A Liquid Biopsy Stock That’s Going Places

The so-called “cure for cancer” isn’t one magical treatment that may or may not be secretly hidden from everyone as part of a vast conspiracy by big pharma. Today’s spray-and-pray approach to cancer treatment has varying degrees of success targeting the over 200 types of cancer, each instance of which is unique to the patient. […]

6 CRISPR Applications from Healthcare Startups

One question we’re often asked at Nanalyze is what emerging technology do we think will be most disruptive in the long term. The short answer: All of them. Otherwise, we wouldn’t be devoting long hours at the laptop between trips to the local dispensary writing about all of this amazing progress. Artificial intelligence, as we’ve […]

An Introduction to Cancer Immunotherapy Treatments

Of all the things that your doctor could tell you that might be a cause for alarm, hearing that you have late-stage cancer is probably one of the worst. We’ve all heard people talk about a “cure for cancer” when in fact there is no one single cure. However things are starting to look up […]

Flatiron: Big Data from Cancer Centers in the Cloud

Cancer isn’t something we like talking about, maybe because it is the cause of one of every four deaths in the United States, and nobody likes talking about death. Almost everyone knows someone who has been affected by cancer, and we all like to throw around the term “a cure for cancer”. The fictional “cure for cancer” […]

Improving Chemotherapy with CorrectChemo

About Chemotherapy Everyone is probably familiar with the term “chemotherapy” as it relates to cancer treatment and the images it evokes are not pleasant ones mainly due to all the negative side effects the treatment is known for. One misconception about “chemotherapy” is that it relates to a single drug or method when in fact […]

Dermtech Offers A Simple Way to Detect Melanoma

The skin is the largest organ of the body, and therefore not surprisingly, skin cancer is the most common of all cancers accounting for nearly half of all cancers in the United States. Skin cancers can be cured easily if they are found early on. The problem is that they cannot be diagnosed visually as […]

Personalized Oncology IPO Epizyme

In earlier articles, we discussed several companies involved in personalizing oncology drugs including Foundation Medicine and Champions Oncology. With plans to personalize therapeutics for genetically defined cancers, one recent IPO, Epizyme, is at the forefront of this growing trend. Business Focus Founded in 2007, Epizyme has taken advantage of sequencing of the human genome by developing […]

A TINY gamble on Champions Oncology

In a previous article we discussed the SEC warning against investing in companies that conduct a reverse merger on the over-the-counter exchange.  However, there are always exceptions to any rule. In looking at Harris and Harris Group’s (NASDAQ:TINY) latest 10-Q we see that TINY has a current investment in an OTC stock called Champions Oncology (OTCMKTS:CSBR). […]